- Home
- CHT vs DXCM Comparison
CHT vs DXCM Comparison
Compare CHT & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHT
- DXCM
- Stock Information
- Founded
- CHT 1996
- DXCM 1999
- Country
- CHT Taiwan
- DXCM United States
- Employees
- CHT N/A
- DXCM N/A
- Industry
- CHT Telecommunications Equipment
- DXCM Medical/Dental Instruments
- Sector
- CHT Telecommunications
- DXCM Health Care
- Exchange
- CHT Nasdaq
- DXCM Nasdaq
- Market Cap
- CHT 34.3B
- DXCM 31.7B
- IPO Year
- CHT 2003
- DXCM 2005
- Fundamental
- Price
- CHT $44.71
- DXCM $77.00
- Analyst Decision
- CHT
- DXCM Strong Buy
- Analyst Count
- CHT 0
- DXCM 19
- Target Price
- CHT N/A
- DXCM $99.89
- AVG Volume (30 Days)
- CHT 114.4K
- DXCM 4.1M
- Earning Date
- CHT 11-05-2025
- DXCM 10-23-2025
- Dividend Yield
- CHT 2.89%
- DXCM N/A
- EPS Growth
- CHT 3.77
- DXCM N/A
- EPS
- CHT 0.17
- DXCM 1.43
- Revenue
- CHT $7,982,762,140.00
- DXCM $4,300,800,000.00
- Revenue This Year
- CHT $4.06
- DXCM $17.03
- Revenue Next Year
- CHT $1.99
- DXCM $15.59
- P/E Ratio
- CHT $26.70
- DXCM $52.83
- Revenue Growth
- CHT 3.95
- DXCM 9.30
- 52 Week Low
- CHT $36.61
- DXCM $57.52
- 52 Week High
- CHT $47.03
- DXCM $93.25
- Technical
- Relative Strength Index (RSI)
- CHT 53.76
- DXCM 45.89
- Support Level
- CHT $43.67
- DXCM $75.39
- Resistance Level
- CHT $45.14
- DXCM $78.96
- Average True Range (ATR)
- CHT 0.37
- DXCM 2.36
- MACD
- CHT 0.10
- DXCM 0.01
- Stochastic Oscillator
- CHT 77.01
- DXCM 43.15
About CHT Chunghwa Telecom Co. Ltd.
Chunghwa Telecom Co Ltd is Taiwan's integrated telecom operator, providing fixed-line, wireless, and Internet and data services. The company segment consists of Consumer Business, Enterprise Business, International Business, and Others. The company generates the majority of its revenue from the Consumer Business segment. The consumer Business segment generates revenue from Mobile services, Fixed-line services, Sales, and others.
About DXCM DexCom Inc.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.